DENTSPLY SIRONA (XRAY) Competitors

Envista (NYSE:NVST) and DENTSPLY SIRONA (NASDAQ:XRAY) are both mid-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, dividends, media sentiment, risk, valuation, profitability, community ranking, analyst recommendations and institutional ownership.

Does the MarketBeat Community favor NVST or XRAY?

DENTSPLY SIRONA received 433 more outperform votes than Envista when rated by MarketBeat users. Likewise, 61.37% of users gave DENTSPLY SIRONA an outperform vote while only 38.20% of users gave Envista an outperform vote.

Company	Underperform	Outperform
Envista	Outperform Votes 34 38.20%	Underperform Votes 55 61.80%
DENTSPLY SIRONA	Outperform Votes 467 61.37%	Underperform Votes 294 38.63%

Does the media favor NVST or XRAY?

In the previous week, DENTSPLY SIRONA had 20 more articles in the media than Envista. MarketBeat recorded 25 mentions for DENTSPLY SIRONA and 5 mentions for Envista. Envista's average media sentiment score of 0.82 beat DENTSPLY SIRONA's score of -0.09 indicating that Envista is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Envista	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
DENTSPLY SIRONA	4 Very Positive mention(s)	1 Positive mention(s)	8 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Which has higher earnings and valuation, NVST or XRAY?

Envista has higher earnings, but lower revenue than DENTSPLY SIRONA. DENTSPLY SIRONA is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Envista	$2.57B	1.38	-$100.20M	-$7.77	-2.65
DENTSPLY SIRONA	$3.97B	0.92	-$132M	-$2.07	-8.83

Do analysts recommend NVST or XRAY?

Envista currently has a consensus target price of $20.71, indicating a potential upside of 0.67%. DENTSPLY SIRONA has a consensus target price of $29.50, indicating a potential upside of 61.38%. Given DENTSPLY SIRONA's stronger consensus rating and higher possible upside, analysts clearly believe DENTSPLY SIRONA is more favorable than Envista.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envista	1 Sell rating(s)	11 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.13
DENTSPLY SIRONA	0 Sell rating(s)	6 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33

Do insiders & institutionals have more ownership in NVST or XRAY?

95.7% of DENTSPLY SIRONA shares are owned by institutional investors. 1.3% of Envista shares are owned by company insiders. Comparatively, 0.5% of DENTSPLY SIRONA shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Which has more volatility & risk, NVST or XRAY?

Envista has a beta of 1.3, suggesting that its stock price is 30% more volatile than the S&P 500. Comparatively, DENTSPLY SIRONA has a beta of 1.02, suggesting that its stock price is 2% more volatile than the S&P 500.

Is NVST or XRAY more profitable?

DENTSPLY SIRONA has a net margin of -10.59% compared to Envista's net margin of -53.42%. DENTSPLY SIRONA's return on equity of 12.62% beat Envista's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Envista	-53.42%	3.76%	2.24%
DENTSPLY SIRONA	-10.59%	12.62%	5.45%

Summary

DENTSPLY SIRONA beats Envista on 11 of the 17 factors compared between the two stocks.